ArticleExperimental and therapeutic medicine2023

Comparison of net adverse clinical events between bivalirudin and heparin as anticoagulants for percutaneous coronary intervention in Chinese patients.

Lina Chai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.